News | September 27, 2013

Company’s portable, non-invasive brain sensing system Nautilus NeuroWave is designed to rapidly and reliably detect abnormal neurological conditions, including ischemic stroke, vasospasm and concussion

September 27, 2013 — Jan Medical and Brainlab announced a collaboration and Series B funding efforts to complete two clinical trials and the subsequent filing of two product 510(k)s with the U.S. Food and Drug Administration (FDA). Brainlab will also add a member representative to the Jan Medical Board of Directors.

Jan Medical has successfully completed a vasospasm study at UCSF Hospital led by Principal Investigator (PI) Professor Wade Smith, M.D. Patients recovering from subarachnoid hemorrhagic (SAH) can suffer symptomatic spasm within the cerebral vasculature leading to cerebral infarction. Current monitoring technologies in the neurocritical care units are not universally applicable, are highly operator dependent and are not always available when needed. The Nautilus NeuroWave is designed to provide simple, reliable monitoring to all patients recovering from SAH and to provide timely information for those managing these critically ill patients.

In other developments, an investigator-led clinical trial by PI Prof. Paul Auerbach M.D., Stanford University, is investigating the possible utility of the Nautilus NeuroWave to detect and track recovery from sports-related concussion.

For more information: www.brainlab.com, www.janmedical.com


Related Content

News | RSNA

Nov. 27, 2022 — ClariPi Inc. has announced that its ClariCT.AI software will be released on Siemens Healthineers’ ...

Time November 27, 2022
arrow
News | RSNA

November 27, 2022— Royal Philips, a global leader in health technology, today announces its portfolio of smart ...

Time November 27, 2022
arrow
News | RSNA

November 23, 2022 — The Radiological Society of North America (RSNA) has announced the official results of the RSNA ...

Time November 23, 2022
arrow
News | Digital Radiography (DR)

November 22, 2022 — Canadian manufacturer KA Imaging is introducing its first mobile X-ray system at the upcoming RSNA ...

Time November 22, 2022
arrow
News | Lung Imaging

November 22, 2022 — Diagnosing early-stage lung cancer with low-dose CT screening drastically improves the long-term ...

Time November 22, 2022
arrow
News | Pediatric Imaging

November 22, 2022 — A new MRI study revealed that consumption of alcohol even in low to moderate amounts during ...

Time November 22, 2022
arrow
News | Lung Imaging

November 21, 2022 — Radiological Society of North America (RSNA) 2022 meeting attendees are invited to visit 4DMedical’s ...

Time November 21, 2022
arrow
News | Artificial Intelligence

November 21, 2022 — The Eureka Clinical AI platform, from ConcertAI’s TeraRecon, now provides clinicians with key ...

Time November 21, 2022
arrow
News | Magnetic Resonance Imaging (MRI)

November 17, 2022 — According to an accepted manuscript published in ARRS’ American Journal of Roentgenology (AJR) ...

Time November 17, 2022
arrow
Feature | RSNA | By Alan Stoddart

Top 10 Predictions for RSNA 2022 was published as an infographic as part of Signify Research's Premium Insights service ...

Time November 17, 2022
arrow
Subscribe Now